Arch Oncology competitorsClear all
Arch Oncology's top competitors include Tollys and Apexigen.
 Arch Oncology Arch Oncology is a clinical-stage immuno-oncology company focused on the discovery and development of antibody therapies for the treatment of patients with cancer. |  Tollys Tollys is a biopharmaceutical company focused on innate immunity, particularly on the biology and modulation of the TLR3 receptor. |  Apexigen Apexigen is a company that develops antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. | |
Founding Date | Founding Date 2006 | Founding Date 2015 | Founding Date 2010 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Brisbane, US HQ St. Louis, US | Locations Lyon, FR HQ Lyon, FR | Locations San Carlos, US HQ |
Employees | Employees 413% increase | Employees N/A | Employees 365% decrease |
Alexa Website Rank | Alexa Website Rank 143845 | Alexa Website Rank N/A | Alexa Website Rank 148563 |
Employee Rating | Employee Rating 4 | Employee Rating N/A | Employee Rating 3.8 |
Funding | |||
Latest funding round | Latest funding round $ 105m (about 1 year ago) | Latest funding round $ 2.5m (about 2 years ago) | Latest funding round $ 65m (about 2 years ago) |
Total funding raised | Total funding raised $ 155m | Total funding raised $ 6.8m | Total funding raised $ 158m |
For sources of this data, please see the company profile
View company profiles
Tollys
HQ
Lyon, FR
Tollys is a biopharmaceutical company focused on innate immunity, particularly on the biology and modulation of the TLR3 receptor.
View companyApexigen
HQ
San Carlos, US
Employees
36↓ 5% decrease
Apexigen is a company that develops antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology.
View company